PTAB Upholds Alcon Patent For Glaucoma Treatment

The Patent Trial and Appeal Board on Thursday upheld the validity of an Alcon patent covering the glaucoma treatment Travatan Z, rejecting arguments by generics maker Argentum that the invention was...

Already a subscriber? Click here to view full article